July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Health State Measurement of Glaucoma Patients
Author Affiliations & Notes
  • Keean Nanji
    McMaster University, Hamilton, Ontario, Canada
  • Gurkaran Singh Sarohia
    Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
  • Dominik Podbielski
    Ophthalmology, University of Toronto, Ontario, Canada
  • Kevin Kennedy
    McMaster University, Hamilton, Ontario, Canada
  • Footnotes
    Commercial Relationships   Keean Nanji, None; Gurkaran Sarohia, None; Dominik Podbielski, None; Kevin Kennedy, Lyceum Health (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4962. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Keean Nanji, Gurkaran Singh Sarohia, Dominik Podbielski, Kevin Kennedy; Health State Measurement of Glaucoma Patients. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4962.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Due to the complex nature of interactive factors in glaucoma management, simulation methods have seen growing use in glaucoma therapy economic evaluations. Factors affecting patient health states were evaluated for their effect on health-related quality of life in data collected for a psychometric validation study to improve the precision of health state measurements and utility values generated in economic simulations.

Methods : The Health Utility for Glaucoma – 5 dimensions (HUG-5) and National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ) instruments were administered to 124 glaucoma patients. Age, gender, ethnicity, education level, marital status, employment status, current cataracts and type of glaucoma were entered in backwards elimination stepwise regressions to identify the magnitude of significant factors influencing health state measured by the NEI-VFQ and the HUG-5. 120 patients were included in the stepwise regression procedure. The mean age (SD) of patients was 66.95 (16.6) with 52 females (43%) and 68 males (57%).

Results : The first model completed in 6 steps; identifying gender, age, and best-eye VFL as the most important predictors of HUG-5 composite scores (F(3,116) = 35.33, R2adj = 0.464, p < 0.001). The second model completed in 4 steps; identifying the same variables as model 1 with the addition of attending post-secondary education and type of glaucoma (mixed-mechanism) in predicting NEI-VFQ-25 composite scores (F(8,111) = 18.24, R2adj = 0.537, p < 0.001).

Conclusions : Gender, age, and best-eye visual field loss should be included to moderate patient level health utility values generated within economic simulations to improve precision of cost-effectiveness patient-level simulations.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×